A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of Presbyopia
Clinical trial NCT03885011 · COMPLETED
Trial details
- NCT number
- NCT03885011
- Sponsor
- Orasis Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-26
- Primary completion
- 2019-07-11
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.